| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4ac3d266bde9bbf5ccd833a951d82ec |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1664
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 |
| filingDate |
2004-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38af9faf1e09f3f16f6f0e8ebec68d02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50c5700256a0f3f28a03923891f66b53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f7d22ed3fb33789493fe919353cd0af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d59d30d0b73bcaba94326c3017b6aa26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d9f31ae09fe62aca7c6d4214d163448
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39be156a1c898cc5a9f72d0eb735f1a3 |
| publicationDate |
2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2581184-T3 |
| titleOfInvention |
Oral phenretinide compositions that have greater bioavailability and methods of use thereof |
| abstract |
An edible composition for oral administration of a retinide comprising, in the form of dry powder suitable for creep: (a) from 1 to 10 percent by weight of the retinide; (b) from 5 to 40 percent by weight of a non-acidic lipid matrix composition, said matrix composition comprising at least one fatty acid, at least one monoglyceride and lysophosphatidylcholine and said lipid matrix composition containing no more than 4 moles of water per mole of lipid matrix; (c) from 1 to 30 percent by weight of sweetener; (d) from 20 to 80 percent by weight of flour; and (e) from 0 to 16 percent by weight of a humectant. |
| priorityDate |
2003-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |